Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Decentralized Clinical Trials Market: By Study Design, By Component, By Application, and Geography
Decentralized Clinical Trials Market: By Study Design, By Component, By Application, and Geography
Decentralized clinical trials market size was valued at US$ 1,675.5 million in 2023 and is expected to grow US$ 4,508.2 million in 2030, at a CAGR of 9.8% from 2024 to 2030. A study executed through telemedicine, mobile, and local healthcare providers using a process of technology differing from the traditional clinical method approach is known as a decentralized clinical trial.
The market is segmented on study design and includes interventional, observational, and expanded access data, observational data are mainly collected from healthcare providers and telemedicine providers. The DCT market is a fast-growing market that provides incorporation with digital clinical trials. The DCT models provide benefits to patients and sponsors as compared to traditional clinical trials. The demand for accurate and high-quality data enhanced patient convenience and experience, lowered the burden of travel, and decreased time-consuming in-patient visits are the major factors driving the market of decentralized clinical trials market.
Regulatory agencies are following various factors for decentralized clinical trials to approach but there is no international standard, which increases the demand for sponsorship for decentralized clinical trials, Although, the reimbursement policies by the government are the key opportunities in the overall Decentralized clinical trials market. Controlling costs, approval from a government authority, recruitment of participants, retaining participants, and completing of trial on time are the major challenges in the decentralized clinical trial. The adoption of artificial intelligence tools for clinical trials is a major recent trend in the market.
Study Period
2024-2030Base Year
2023CAGR
9.8%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increasing prevalence of mobile healthcare and the increase in sponsorship in a clinical trials in the world is the major market driver in the Decentralized Clinical Trials Market during the forecast period. Enhanced patient convenience towards health care and skilled professional for health consultants are major demand in the market, also in pharmaceutical to increase research and development activity, with this increasing number of clinical trials and high cost for drug manufacturing also in R&D facility, are dependent on data and information from outsourced firms, increased in the demand for sponsorship for decentralized clinical trials. Hence, this will drive global market growth at a significant rate.
Based on regions, the market share is divided into North America, Asia-Pacific, Europe, the Middle East, and the African region. The Decentralized clinical trials market in the Asia Pacific is likely to hold a significant revenue share in 2021, and, in the following years, it is predicted to increase rapidly. It is attributed to the increasing number of research and development activities for novel medications and vaccines, and the rapidly growing well-developed healthcare infrastructure. In Japan and India, the pharmaceuticals and medical device companies are promoting DCTs in the region with the support of government bodies’ new technology introduced to increase clinical trials in the region. North America holds the major market share in the global market and is expected to dominate the market in the upcoming years due to global key players such as IQVIA, LabCorp, and others in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,675.5 million |
|
Market Size in 2030 |
US$ 4,508.2 million |
|
Market CAGR |
9.8% |
|
By Study Design |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global decentralized clinical trials market size was valued at US$ 1,675.5 million in 2023 and is projected to grow at a CAGR of 9.8% from 2024 to 2030.
A study executed through telemedicine, mobile, and local healthcare providers using the process of technology differs from the traditional clinical method approach is known as a decentralized clinical trial.
The leading players in the Decentralized Clinical Trials Market are; Medidata, IQVIA, LabCorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health, Clinical Ink, Medable, Science 37, LEO Innovation Lab, Covance, Thermo Fisher, Huma, Signant Health
Historic years considered for the market study are 2018 through 2022, 2022 is considered as the base year for market estimation, and Seven years forecast is presented from 2023 – 2029.
| 1.Executive Summary |
| 2.Global Decentralized Clinical Trials Market Introduction |
| 2.1.Global Decentralized Clinical Trials Market - Taxonomy |
| 2.2.Global Decentralized Clinical Trials Market - Definitions |
| 2.2.1.Study Design |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Decentralized Clinical Trials Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Decentralized Clinical Trials Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Decentralized Clinical Trials Market By Study Design, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Interventional |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Observational |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Expand Access |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Decentralized Clinical Trials Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Peripheral Vascular Disease |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Oncology |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Neurology |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Urology |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Decentralized Clinical Trials Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Centers |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Decentralized Clinical Trials Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Decentralized Clinical Trials Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Study Design Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Interventional |
| 9.1.2.Observational |
| 9.1.3.Expand Access |
| 9.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Peripheral Vascular Disease |
| 9.2.2.Oncology |
| 9.2.3.Neurology |
| 9.2.4.Urology |
| 9.2.5.Others |
| 9.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ambulatory Surgical Centers |
| 9.3.3.Diagnostic Centers |
| 9.3.4.Others |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Decentralized Clinical Trials Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Interventional |
| 10.1.2.Observational |
| 10.1.3.Expand Access |
| 10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Peripheral Vascular Disease |
| 10.2.2.Oncology |
| 10.2.3.Neurology |
| 10.2.4.Urology |
| 10.2.5.Others |
| 10.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ambulatory Surgical Centers |
| 10.3.3.Diagnostic Centers |
| 10.3.4.Others |
| 10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Decentralized Clinical Trials Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Interventional |
| 11.1.2.Observational |
| 11.1.3.Expand Access |
| 11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Peripheral Vascular Disease |
| 11.2.2.Oncology |
| 11.2.3.Neurology |
| 11.2.4.Urology |
| 11.2.5.Others |
| 11.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ambulatory Surgical Centers |
| 11.3.3.Diagnostic Centers |
| 11.3.4.Others |
| 11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Decentralized Clinical Trials Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Interventional |
| 12.1.2.Observational |
| 12.1.3.Expand Access |
| 12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Peripheral Vascular Disease |
| 12.2.2.Oncology |
| 12.2.3.Neurology |
| 12.2.4.Urology |
| 12.2.5.Others |
| 12.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ambulatory Surgical Centers |
| 12.3.3.Diagnostic Centers |
| 12.3.4.Others |
| 12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Decentralized Clinical Trials Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Interventional |
| 13.1.2.Observational |
| 13.1.3.Expand Access |
| 13.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Peripheral Vascular Disease |
| 13.2.2.Oncology |
| 13.2.3.Neurology |
| 13.2.4.Urology |
| 13.2.5.Others |
| 13.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ambulatory Surgical Centers |
| 13.3.3.Diagnostic Centers |
| 13.3.4.Others |
| 13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Medidata |
| 14.2.2.IQVIA |
| 14.2.3.LabCorp |
| 14.2.4.PRA Health Sciences |
| 14.2.5.Parexel |
| 14.2.6.ICON |
| 14.2.7.Oracle |
| 14.2.8.CRF Health |
| 14.2.9.Clinical Ink |
| 14.2.10.Medable |
| 14.2.11.Science 37 |
| 14.2.12.LEO Innovation Lab |
| 14.2.13.Covance |
| 14.2.14.Thermo Fisher |
| 14.2.15.Huma |
| 14.2.16.Signant Health |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.